These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 15062763

  • 1. Experience with the IVDD performance evaluations of the ADVIA Centaur infectious disease assays.
    van Helden J, Denoyel GA.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S16-8. PubMed ID: 15062763
    [No Abstract] [Full Text] [Related]

  • 2. The ADVIA Centaur immunoassay system--designed for infectious disease testing.
    Okrongly D.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S19-22. PubMed ID: 15062764
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P, Pickard G, Gammie A, Atkins M.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [Abstract] [Full Text] [Related]

  • 4. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
    Dati F, Denoyel G, van Helden J.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
    [Abstract] [Full Text] [Related]

  • 5. The ADVIA Centaur infectious disease assays: a technical review.
    Dwyer R.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S1-5. PubMed ID: 15062760
    [Abstract] [Full Text] [Related]

  • 6. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B.
    Clin Lab; 2004 Apr; 50(1-2):63-73. PubMed ID: 15000222
    [Abstract] [Full Text] [Related]

  • 7. An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System.
    Dati F.
    Clin Lab; 2004 Apr; 50(1-2):53-61. PubMed ID: 15000221
    [Abstract] [Full Text] [Related]

  • 8. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
    Denoyel G, van Helden J, Bauer R, Preisel-Simmons B.
    Clin Lab; 2004 Apr; 50(1-2):75-82. PubMed ID: 15000223
    [Abstract] [Full Text] [Related]

  • 9. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E, Kuştimur S, Doğruman Al F.
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.
    Chen D, Kaplan L, Liu Q.
    Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476
    [Abstract] [Full Text] [Related]

  • 11. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
    van Helden J, Denoyel G, Freeman J, Preisel-Simmons B.
    Clin Lab; 2004 May; 50(1-2):83-90. PubMed ID: 15000224
    [Abstract] [Full Text] [Related]

  • 12. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
    van Helden J, Cornely C, Dati F, Levy HR, Bal T, Seeger M, Wright T, Baker L.
    J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Hart IJ, Munthali C, Beeching NJ, Zijlstra EE.
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [Abstract] [Full Text] [Related]

  • 14. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M, Legrand-Abravanel F, Lalanne C, Saune K, Izopet J.
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [Abstract] [Full Text] [Related]

  • 15. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].
    Dray X, Dray-Spira R, Bronstein JA, Mattera D.
    Med Trop (Mars); 2005 Feb; 65(1):39-42. PubMed ID: 15903075
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the clinical performance of the Beckman Coulter Access AbHBsII immunoassay for the detection of hepatitis B surface antibodies.
    Motte A, Colson P, Tamalet C.
    J Clin Virol; 2006 Nov; 37(3):213-7. PubMed ID: 17010665
    [Abstract] [Full Text] [Related]

  • 17. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B, Meriç M, Willke A.
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [Abstract] [Full Text] [Related]

  • 18. [Detection of hepatitis B and hepatitis C markers in HIV positive patients, 2000-2004].
    Bello Corredor M, Rodríguez Lay Lde L, Gutiérrez Moreno A, Sariego Frómeta S, Montalvo Villalba MC, Sánchez Sol A.
    Rev Cubana Med Trop; 2005 Oct; 57(3):212-3. PubMed ID: 17969276
    [Abstract] [Full Text] [Related]

  • 19. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    La'ulu SL, Roberts WL.
    Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
    Haltmayer M, Mueller T, Gegenhuber A, Poelz W.
    Clin Lab; 2004 May; 50(3-4):175-80. PubMed ID: 15074472
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.